Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH Related Cirrhosis”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Not applicableUnknownNCT04057287
What this trial is testing

Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)

Who this might be right for
Liver Cirrhoses
Institute of Liver and Biliary Sciences, India 670
Large-scale testing (Phase 3)Study completedNCT01371825
What this trial is testing

Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency

Who this might be right for
Lysosomal Acid Lipase DeficiencyWolman Disease
Alexion Pharmaceuticals, Inc. 9
Not applicableActive Not RecruitingNCT06315361
What this trial is testing

DIAbetes and NAFLD

Who this might be right for
NAFLDDiabetesNASH+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600
Not applicableLooking for participantsNCT04666402
What this trial is testing

Integrated Diagnostics for Early Diagnosis of Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisAlcoholic Liver Disease+1 more
Manchester University NHS Foundation Trust 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT05832229
What this trial is testing

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Who this might be right for
CirrhosisCirrhosis, LiverCirrhosis Early+5 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 256
Large-scale testing (Phase 3)Active Not RecruitingNCT05500222
What this trial is testing

Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Who this might be right for
NASHCirrhosis, Liver
Madrigal Pharmaceuticals, Inc. 845
Not applicableLooking for participantsNCT05385237
What this trial is testing

Identification of Hepatic Fibrosis Using 4D-MRI

Who this might be right for
Liver Diseases
University Hospital, Basel, Switzerland 200
Not applicableWithdrawnNCT02868164
What this trial is testing

Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.

Who this might be right for
NASH Related Decompensated Cirrhosis
Institute of Liver and Biliary Sciences, India
Not applicableStudy completedNCT02234440
What this trial is testing

Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance

Who this might be right for
NASH Related Cirrhosis
Institute of Liver and Biliary Sciences, India 86
Not applicableUnknownNCT04493814
What this trial is testing

Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients

Who this might be right for
NAFLDType 2 Diabetes
Central Hospital, Nancy, France 86
Testing effectiveness (Phase 2)Ended earlyNCT02193867
What this trial is testing

Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency

Who this might be right for
Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals, Inc. 10
Not applicableLooking for participantsNCT05974904
What this trial is testing

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseHepatic SteatosisLiver Fibrosis
Chongqing Medical University 7,000
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableStudy completedNCT04146636
What this trial is testing

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study)

Who this might be right for
NAFLDAlcohol-Related DisorderLiver Fibrosis
University Hospital, Angers 282
Not applicableNot Yet RecruitingNCT06135584
What this trial is testing

Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseCirrhosis
The Affiliated Hospital of Hangzhou Normal University 1,000
Not applicableUnknownNCT02721264
What this trial is testing

Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.

Who this might be right for
Non Alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India 112
Not applicableNot Yet RecruitingNCT06364462
What this trial is testing

Precise Evaluation Criteria for Histological Regression of NASH Fibrosis

Who this might be right for
NASHLiver Fibrosis
Beijing Friendship Hospital 220
Not applicableLooking for participantsNCT05699018
What this trial is testing

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Alcoholic Liver Disease (ALD)Liver Fibrosis
University Hospital, Angers 1,788
Not applicableLooking for participantsNCT03308916
What this trial is testing

Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers

Who this might be right for
Liver Diseases, AlcoholicFibrosis
Maja Thiele 6,500
Next Page